WestEnd Advisors’s Boston Scientific BSX Stock Holding History

WestEnd Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.92K	Hold	44	–	–	﹤0.01%	210
2026 Q2	$1.88K	Buy	44 +6	+16%	+$326	﹤0.01%	193
2026 Q1	$2.38K	Hold	38	–	–	﹤0.01%	142
2025 Q4	$3.62K	Sell	38 -6	-14%	-$588	﹤0.01%	117
2025 Q3	$4.3K	Sell	44 -20	-31%	-$2.07K	﹤0.01%	106
2025 Q2	$6.87K	Buy	64 +7	+12%	+$708	﹤0.01%	89
2025 Q1	$5.75K	Buy	57 +38	+200%	+$3.83K	﹤0.01%	89
2024 Q4	$1.7K	Buy	19 +2	+12%	+$176	﹤0.01%	108
2024 Q3	$1.42K	Sell	17 -1	-6%	-$79	﹤0.01%	106
2024 Q2	$1.39K	Sell	18 -5	-22%	-$366	﹤0.01%	101
2024 Q1	$1.58K	Buy	23 +1	+5%	+$64	﹤0.01%	97
2023 Q4	$1.27K	Buy	22 +2	+10%	+$107	﹤0.01%	108
2023 Q3	$1.06K	Buy	+20	New	+$1.05K	﹤0.01%	106
2023 Q1	–	Sell	-18	Closed	-$848	–	109
2022 Q4	$833	Hold	18	–	–	﹤0.01%	109
2022 Q3	$1K	Hold	18	–	–	﹤0.01%	100
2022 Q2	$670	Buy	+18	New	+$733	﹤0.01%	125
2022 Q1	–	Sell	-11	Closed	-$477	–	138
2021 Q4	$467	Buy	+11	New	+$462	﹤0.01%	161
2021 Q3	–	Hold	0	–	–	–	151
2021 Q2	–	Hold	0	–	–	–	154

Other funds holding BSX

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

WestEnd Advisors's BSX Position: Q3 2026 in Review

WestEnd Advisors held its Boston Scientific (BSX) position steady in Q3 2026 at 44 shares worth $1.92K. The position accounts for ﹤0.01% of the portfolio, ranked #210.

WestEnd Advisors first reported a position in BSX in Q4 2021 and has held it in 17 quarters since. The position peaked at $6.87K in Q2 2025. 835 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

WestEnd Advisors held 44 shares of Boston Scientific worth $1.92K as of Q3 2026.
WestEnd Advisors left its Boston Scientific share count unchanged in Q3 2026.
Boston Scientific made up ﹤0.01% of WestEnd Advisors's portfolio in Q3 2026, its #210 holding.
WestEnd Advisors first reported a position in Boston Scientific in Q4 2021 and has held it in 17 quarters since.
WestEnd Advisors's Boston Scientific position peaked at $6.87K in Q2 2025.
835 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on WestEnd Advisors's 13F filing for Q3 2026, filed 27 Oct 2026.